David M. Ansley

Large-Dose Propofol During Cardiopulmonary Bypass Decreases Biochemical Markers of Myocardial Injury in Coronary Surgery Patients: A Comparison with Isoflurane

Zhengyuan Xia, Zhiyong Huang, David M. Ansley · Anesthesia & Analgesia · 2006 · 134 citations

Medicine, Perioperative Medicine, Pharmacology +15

Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation

Baohua Wang, Jayant Shravah, Honglin Luo et al. · Biochemical and Biophysical Research Communications · 2009 · 103 citations

Life Sciences, Molecular Biology, Pharmacology +12

Tissue Antioxidant Capacity During Anesthesia: Propofol Enhances In Vivo Red Cell and Tissue Antioxidant Capacity in a Rat Model

Tim D. Runzer, David M. Ansley, David V. Godin et al. · Anesthesia & Analgesia · 2002 · 94 citations

Life Sciences, Anesthesiology, Pharmacology +17

Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease

Zhengyuan Xia, Jiazhen Gu, David M. Ansley et al. · Journal of Thoracic and Cardiovascular Surgery · 2003 · 71 citations · Full text

Medicine, Cardiology, Pharmacology +12

Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F_2t-isoprostane formation

Zhengyuan Xia, David V. Godin, Thomas K. H. Chang et al. · Canadian Journal of Physiology and Pharmacology · 2003 · 70 citations

Medicine, Cardiology, Pharmacology +15